Rick E Winningham
2014 - Theravance Biopharma
In 2014, Rick E Winningham earned a total compensation of $14.9M as Chief Executive Officer at Theravance Biopharma, a 752% increase compared to previous year.
Compensation breakdown
| Bonus | $627,526 |
|---|---|
| Option Awards | $6,934,728 |
| Salary | $738,724 |
| Stock Awards | $6,597,645 |
| Other | $500 |
| Total | $14,899,123 |
Winningham received $6.9M in option awards, accounting for 47% of the total pay in 2014.
Winningham also received $627.5K in bonus, $738.7K in salary, $6.6M in stock awards and $500 in other compensation.
Rankings
In 2014, Rick E Winningham's compensation ranked 234th out of 13,032 executives tracked by ExecPay. In other words, Winningham earned more than 98.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 234 out of 13,032 | 98th |
Division Manufacturing | 90 out of 4,966 | 98th |
Major group Chemicals And Allied Products | 34 out of 1,686 | 98th |
Industry group Drugs | 28 out of 1,365 | 98th |
Industry Pharmaceutical Preparations | 26 out of 1,043 | 98th |
Source: SEC filing on March 25, 2016.
Winningham's colleagues
We found two more compensation records of executives who worked with Rick E Winningham at Theravance Biopharma in 2014.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019